This report is FREE today only!
Genzyme (GENZ) Stock Quotes & Symbols
Get Expert Advice & Free Trading Report for GENZ
Report Preview
I Answer Questions
via 1-1 Live Chat
- Trading Plans for GENZ
- Stock Traders Daily
- Multi Tiered Analysis
- Free
- Unbiased long/short strategies
- Adobe Acrobat®
- Included
- Also available for $18 through Reuters
Report Details
Empower Your Competitive Advantage.
Genzyme (GENZ) Stock Quote Price Graph
Genzyme (GENZ) Stock Quote Information
Genzyme Corporation operates as a biotechnology company worldwide. It focuses on rare genetic disease disorders, renal diseases, orthopaedics, cancers, transplant and immune diseases, and diagnostic and predictive testing areas. The company?s Genetic Diseases segment manufactures and distributes Cerezyme for the treatment of Gaucher disease; Fabrazyme for the treatment of Fabry disease; Myozyme for the treatment of Pompe disease; Aldurazyme for the treatment of Mucopolysaccharidosis I; and Elaprase for the treatment of Mucopolysaccharidosis II. Its Cardiometabolic and Renal segment offers Renagel and Renvela for the control of serum phosphorus in patients with chronic kidney disease on dialysis; Hectorol for the treatment of secondary hyperparathyroidism; and Thyrogen, an adjunctive diagnostic agent used in the follow-up of patients with well-differentiated thyroid cancer. The company?s Biosurgery segment provides Synvisc, a biomaterial-based product that is used to treat the pain associated with osteoarthritis of the knee; and Sepra family of products to prevent adhesions following various surgical procedures in the abdomen and pelvis. Its Hematologic Oncology segment develops products for the treatment of cancer, including Campath and Fludara for the treatment of leukemia and lymphoma; Clolar for the treatment of acute leukemia; Leukine for the reduction of the incidence of severe and life-threatening infections in older adult patients with AML following chemotherapy and certain other uses; and Mozobil for the mobilization of hematopoietic stem cells. The company has strategic alliances with Bayer; Osiris Therapeutics, Inc.; PTC Therapeutics, Inc.; and Isis Pharmaceuticals, Inc. It serves physicians, hospitals, treatment centers, other providers of medication to patients, retail pharmacies, and government agencies through distributors. The company was founded in 1981 and is based in Cambridge, Massachusetts.
Buy and Hold is Dead
10 Day Free Trial Offer
Here are a few of the services we offer. Sign up for a Free Trial to find out more.
The Investment Rate is the most accurate leading longer term stock market and economic indicator ever developed. It is the foundation of everything we do. The IR measures the rate of change in the amount of new money available for investment into our economy every year, and for extended periods of time. If has predicted the Great Depression, the Stagflation Period of the 1970s, and the up-periods in between. It impacts all asset classes: stocks, real estate, private business, and any other asset class that relies on new money to grow. Use it to make investment decisions and business decisions. The accuracy is unparalleled. Find out what it says about the immediate future by signing up for a free trial, and see if your decisions line up with the most accurate leading economic indicator in history.
Most money managers do not control risk. They get paid to invest money, not to move it to cash. You must control your own risk; you have to. This is not an option. However, it does not have to be complicated either. Our services are designed to make the transition to risk control seamless. We all know we should do it, now anyone can do it. All of our strategies are focused on risk control and wealth preservation. Performance is a natural byproduct. Stop chasing performance, and start chasing risk control. You will be happier, and better off. Sign up for a free trial to see how our services can make risk control and opportunity paradigm for you too.
A revolution in rule based trading. Trend Tracker is an
automated - correlated market timing and stock selection tool
that allows normal people, with normal jobs, to control their
risk and realize opportunities regardless of economic conditions
or market direction, and without sacrificing time or lifestyle.
Work, play golf, or trade other stocks, and feel confident that
your wealth is being protected and that you are positioning
yourself to profit when opportunities arise.
Sign up for a free trial to learn more.
We offer trading reports on 1300 different companies through Reuters.